1986: Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs. Updated in 1994.
DeAnda
A
A
Department of Cardiovascular and Thoracic Surgery, Falk Cardiovascular Research Center, Stanford University School of Medicine, CA 94305-5247.
Miller
D C
DC
D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology; D002315:Cardiopulmonary Bypass; D004285:Dogs; D006487:Hemostasis / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D011725:Pyridines / Q000494:pharmacology*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D007093:Imidazoles; D011725:Pyridines; D007611:Aprotinin; C037787:pirmagrel; D013930:Thromboxane-A Synthase